*All CONTOUR™NEXT and CONTOUR™PLUS meter systems meet ISO 15197:2013 accuracy requirements which stipulate that 95% of the measured glucose values need to fall within either ±15 mg/dL of the average measured values of the reference measurement procedure at glucose concentrations <100 mg/dL or within ±15% at glucose concentrations ≥100 mg/dL.
†Compatible Medtronic devices include MiniMed™ Paradigm® Veo™ insulin pump, MiniMed™ Paradigm®REAL-Time insulin pump and continuous glucose monitoring (CGM) system, and Guardian®REAL-Time CGM system.
This site is intended to provide information to an international audience outside the US and does not provide medical advice. Not all products discussed on this site may be available in your country.
Please consult your healthcare provider for guidance about a specific medical condition and before making any healthcare decisions.
Ascensia, the Ascensia Diabetes Care logo, CONTOUR, No Coding, the No Coding logo, Second-Chance, Sip-in sampling (reg'd), smartALERTS and smartLIGHT are trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are the property of their respective owners.
Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google Inc.